Gene Query: GADD45GIP1

Dataset Description Geneva Score
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 32.05
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 29.49
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 29.01
Genome wide expression change in LCC2 and MCF-7 cells 28.17
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 26.68
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 25.71
The comparison of high-throughput single-cell RNA-seq methods 25.27
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 24.09
Differential gene expression of human melanoma cells [RNA-seq] 24.09
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 23.47
Impact of dieldrin on transcription in Jurkat T cells 22.47
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 20.76
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 20.65
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 20.38
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 20.29
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 19.88
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 19.83
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 19.61
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 19.61
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 19.51
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 19.34
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 19.34
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 19.23
METTL3 promotes translation in human cancer cells 18.69
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 18.69
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 18.52
Comprehensive comparative analysis of 5’ end RNA sequencing methods 18.28
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 17.96
NRDE2 negatively regulates nuclear exosome functions 17.33
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 17.25
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 17.25
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 17.16
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 17.16
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 16.92
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 16.72
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 16.61
Global analysis of enhancer targets: Mosaic-seq 15.82
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 15.78
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 15.78
Role of microRNAs in the interaction between Salmonella and the host cell 15.38
EWSR1 influences alternative splicing through direct and indirect mechanisms 15.0
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.98
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 14.87
hTERT promotes cell adhesion and migration independent of telomerase activity 14.57
Differentiation enhances Zika virus infection in neuronal brain cells 14.32
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 14.24
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 14.04
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 13.8
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 13.74
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 13.61
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 13.54
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 13.47
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 13.18
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 13.18
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 13.11
Transcriptome analysis of SKI knock-out in HL60 cells 13.11
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 13.01
Total RNA-seq in ALL-SIL upon JQ1 inhibition 12.99
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 12.97
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 12.96
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 12.87
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 12.71
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.57
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 12.54
HNF1A deficiency impairs β-cell fate, granule maturation and function 12.52
miR941 overexpression experiment 12.22
Regulation of poly(A) tail and translation during the somatic cell cycle 12.11
Patient-derived luminal breast cancer xenografts with progestins 12.08
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 12.08
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 12.01
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 11.77
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 11.72
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 11.53
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 11.51
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 11.48
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 11.37
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 11.2
CROP-Seq in Primary Human T Cells 10.99
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 10.97
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 10.87
Gene expression changes due to PARP knockdown in human cells 10.85
SLAM-seq for K562 endogenous mRNA decay 10.84
Regulation of highly expressed hCINAP on translatome 10.72
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 10.68
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 10.68
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 10.68
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 10.6
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 10.55
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 10.55
Survival of pancreatic cancer cells lacking KRAS function 10.49
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 10.37
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 10.34
RNA sequencing of primary human platelets and in vitro cell lines 10.33
Gene expression changes caused by KRAS in MCF-10A 10.3
Trans-differentiation of human adult peripheral blood T cells into neurons 10.23
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 10.2
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.2
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 10.18
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.16
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 9.99
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 9.99
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.98
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 9.95
Generating Patterned Kidney Organoids for Studying Development and Diseases 9.93
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 9.89
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 9.89
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 9.84
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 9.84
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 9.81
Gene expression profiling of leukemia cells following asparagine depletion 9.77
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 9.72
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 9.72
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 9.71
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 9.7
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 9.67
High-throughput sequencing of PROMPT-enriched samples. 9.64
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 9.61
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 9.6
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 9.57
High-throughput sequencing of pluripotent cells 9.55
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 9.5
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.49
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 9.48
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 9.43
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 9.41
Transcription control by the ENL YEATS domain in acute leukemia 9.28
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 9.28
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 9.26
Genome wide expression change by RNF168 knocking down in NEC cells 9.21
miRNAs affected by antagomiR-17 treatment 9.14
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 9.13
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 9.11
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 9.11
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 9.07
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 9.02
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 8.92
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 8.9
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 8.89
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.84
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.84
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.69
U1 snRNP telescripting regulates size-function stratified human genome 8.69
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.65
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 8.62
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 8.58
Peptidomimetic blockade of MYB in acute myeloid leukemia 8.58
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 8.57
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 8.56
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 8.54
RNA-seq analysis of the human fetal kidney. 8.52
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 8.48
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 8.47
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  8.46
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 8.43
SETBP1-WT and SETBP1-G870S epigenetic landscapes 8.43
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 8.43
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 8.41
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 8.38
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.37
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.37
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.37
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 8.34
The evolution of N6-methyladenosine in primates 8.33
Triple vectors expand AAV transfer capacity in the retina 8.29
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 8.29
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 8.29
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 8.25
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.25
Lysine benzoylation is a novel histone mark 8.16
Lysine benzoylation is a novel histone mark [RNA-seq] 8.16
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 8.14
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 8.14
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 8.12
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 8.11
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 8.11
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 8.09
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 8.07
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 8.06
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 8.06
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 7.97
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 7.87
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 7.87
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 7.84
Mutational landscape of splicing genes and functional consequences across 33 cancer types 7.82
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 7.8
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.78
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 7.77
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 7.76
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 7.75
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 7.66
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 7.64
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.61
MYCi975 regulates MYC target genes 7.6
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 7.56
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.56
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 7.55
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 7.55
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 7.52
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 7.51
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 7.5
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 7.49
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 7.4
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 7.39
Landscape and variation of RNA secondary structure across the human transcriptome 7.36
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 7.35
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.33
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 7.31
Metastasis in triple-negative breast cancer 7.31
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 7.24
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 7.22
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 7.16
Gene expression signatures of innate lymphoid cells from human blood 7.14
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 7.13
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.11
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 7.02
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 7.01
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.97
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.97
Identification of HOXB13 target genes responsive to BET inhibitors 6.97
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 6.97
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.93
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.9
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.9
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 6.9
HEK293 Heat-shock experiment 6.89
RNA editing in nascent RNA affects pre-mRNA splicing 6.88
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 6.87
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 6.87
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 6.86
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 6.86
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 6.84
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 6.84
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.83
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.83
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.81
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 6.8
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.73
Genetic-to-epigenetic Therapy for Pancreatic Cancer 6.72
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 6.65
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 6.64
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 6.62
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.59
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.59
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 6.59
N6-methyladenine DNA Modification in Glioblastoma 6.58
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.58
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 6.57
Illumina Total RNA-seq in HeLa 6.52
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 6.52
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 6.52
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.49
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.49
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 6.48
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 6.47
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.46
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 6.45
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 6.4
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 6.37
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 6.33
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 6.27
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 6.25
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 6.24
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 6.2
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 6.2
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 6.18
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 6.17
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 6.14
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 6.11
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.08
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 6.06
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 6.06
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.05
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 5.99
Transcriptome sequencing of K-562 cells 5.97
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 5.97
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.94
Human Treg IL-12 stimulation 5.93
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.93
Effect of from Human Umbilical Vein Endothelial Cells 5.92
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 5.86
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 5.86
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 5.84
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.82
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.76
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.7
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.7
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 5.68
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.63
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 5.61
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 5.61
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 5.56
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 5.47
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 5.47
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.42
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.42
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.37
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 5.36
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.36
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.33
Functional role of CPPED1 in trophoblasts. 5.32
Active translatome profiling with RiboLace in MCF7 cells 5.29
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 5.24
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 5.24
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.19
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 5.12
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.11
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 5.03
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 5.03
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 5.0
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.97
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 4.96
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.96
RNA seq with AML (NB4) cells upon FTO inhibition 4.94
Primate transcript and protein expression levels evolve under compensatory selection pressures 4.93
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.92
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.91
RNA-seq of naive and primed ES cells (NHSM) 4.9
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 4.88
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 4.87
Single-cell analysis of human kidney organoids 4.69
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.67
Hepatitis C virus functionally sequesters miR-122 4.67
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 4.63
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.62
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.6
Positively selected enhancer elements endow tumor cells with metastatic competence 4.57
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.57
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 4.57
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 4.56
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.55
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 4.53
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.48
The transcriptome effect of overexpressing EZH2 in MCF7 4.48
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 4.46
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 4.45
Effect of FGF13 depletion on the H460 cell line 4.44
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.4
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 4.37
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.37
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 4.35
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.35
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 4.33
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 4.33
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 4.33
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.31
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.3
RNA-seq analysis upon ARID1B overexpression 4.27
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 4.25
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 4.2
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 4.12
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 4.08
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 4.07
K562 polyA RNA-Seq 4.05
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 4.04
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 4.04
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.94
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.94
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 3.93
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.92
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 3.92
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 3.91
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.89
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.89
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.87
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.86
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 3.83
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.76
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.76
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.76
RNAseq of cell lines with knocked in ESR1 mutations 3.74
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.67
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.67
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.66
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.62
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 3.59
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.55
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.47
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.47
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.46
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 3.42
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.36
Ribosome profiling upon inhibition of eIF4A 3.35
Gene expression profiling of papillary thyroid cancer from central and invasive regions 3.31
The cohesin complex prevents Myc-induced replication stress 3.29
RNA-Seq of PRMT1 overexpression ECA109 cells 3.28
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.01
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.96
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.93
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 2.92
IMP3 regulated gene expression in breast cancer cells 2.86
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.85
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.85
Gene expression profile in breast cancer cells 2.81
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.81
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.79
Expression analysis of the TAF1 syndrome 2.71
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.7
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.65
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.5
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.48
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.45
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 2.43
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 2.43
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.39
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.29
Comparative Analysis of Cas9 Activators Across Multiple Species 2.25
Energy Metabolism during Anchorage-Independence 2.24
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.17
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.14
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.12
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.12
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.1
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.09
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.08
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.05
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.03
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.93
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.89
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.85
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.84
A map of gene expression in neutrophil-like cell lines 1.82
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.8
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.8
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.8
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.79
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.75
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.75
Profiling of escape kinetics of viruses subjected to RNAi 1.65
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.65
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.65
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.64
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.63
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.43
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.38
Investigate A2M treatment on human prostate cancer xenograft in mice 1.37
Investigate A2M treatment on human prostate cancer and mouse liver 1.37
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.36
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.36
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.33
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 1.28
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.26
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.26
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.25
SRSF1 role in cellular gene expression and splicing 1.2
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.17
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.15
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.07
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.07
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.07
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.04
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.99
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.98
The circadian transcriptional landscape in primary human mammary epithelial cells 0.96
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.93
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.92
Copper Regulation of HIF-1 Transcription Activity 0.92
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.88
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.86
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.83
Enhancer activation during EGF response 0.83
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.76
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.74
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.74
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.74
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 0.67
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.64
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.64
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.62
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.54
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.52
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.52
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.51
RNA-seq data 0.5
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.49
miR-93 Targets in Human Endothelial Cells 0.48
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.47
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.45
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.43
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.42
Transcriptome-wide modulation of splicing by the exon junction complex 0.37
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.33
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.33
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.32
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.31
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.28
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.17
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.17
Genome-wide analysis of the Integrator complex (HTS) 0.14
Genome-wide analysis of the Integrator complex 0.14
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.14
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.1
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 0.1
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.1
Iron response of HepG2 cells 0.09
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.07
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.07
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.07
The bromodomain protein BRD4 regulates splicing during heat shock 0.06
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.05
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation